Android app on Google Play

Ampio (AMPE) Submits Pre-IND Package on Zertane to FDA

April 9, 2012 7:07 AM EDT Send to a Friend
Get Alerts AMPE Hot Sheet
Trade AMPE Now!
Join SI Premium – FREE
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) has submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.




You May Also Be Interested In


Related Categories

Corporate News, FDA

Add Your Comment